ArticleOncoimmunology2020

Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination.

Wouter W van Willigen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.